NCT01669031

Brief Summary

Unreliability and visual field variability is a known problem with automated perimetry in both developing and developed country settings. This study will look at the effects of a computer program that allows new patients to practice the visual field exam before taking the actual exam. Our hypothesis is that the intervention group will have less variability as measured by mean deviation between exams and greater reliability as measured by the standard unreliability indexes of false positive rate, false negative rate, and fixation losses.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

August 16, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 20, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

August 20, 2012

Status Verified

August 1, 2012

Enrollment Period

9 months

First QC Date

August 16, 2012

Last Update Submit

August 16, 2012

Conditions

Keywords

automated perimetryvisual fieldsreliabilityvision tests/standardsrandomized controlled trialfalse positive reactionsfalse negative reactionsfixation, ocularmean deviationvariabilityprogramsoftwareglaucoma/diagnosisvisual field tests/methodsagedhumansfemalemaleprospective studiesreproducibility of results

Outcome Measures

Primary Outcomes (1)

  • The absolute value of the difference in mean deviation of the first and second visual field exam

    Visual field exams obtained 1 to 2 weeks apart

Secondary Outcomes (4)

  • Difference in the absolute number of altered points in the visual field with a total deviation below the 0.5 percentile

    Visual field exams obtained 1 to 2 weeks apart

  • Difference in the percentage of false positives, false negatives, and fixation losses at the first and second exam between control and intervention group

    Visual field exams obtained 1 to 2 weeks apart

  • Difference in the time required to complete the first and second exam

    Visual field exams obtained 1 to 2 weeks apart

  • Difference in the proportion of unreliable visual fields at the first and second exam between control and intervention groups

    Visual field exams obtained 1 to 2 weeks apart

Study Arms (2)

Control Group

NO INTERVENTION

No practice tests are performed in this arm

Practice Program

EXPERIMENTAL

At the 3 study visits exposed to a training session (simulated visual field test on a computer). Visit 1 they get 2 simulated tests tests per eye. At visits 2 and 3 they get 1 simulated test per eye. Each simulated test takes 3-15 minutes

Other: Practice program

Interventions

Each practice session (simulated visual field test on computer) takes 3-15 minutes

Also known as: Computer Simulated practice Visual Field Test
Practice Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or greater
  • Referred to the glaucoma clinic for examination due to suspected glaucoma or glaucoma diagnosis
  • No more than 1 automated visual field test within the last 4 years

You may not qualify if:

  • patients who cannot remain seated for 10 minutes
  • patients with neck problems that prevent them from using the field analyzer properly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Sótero del Río

Santiago, Puente Alto, Chile

RECRUITING

MeSH Terms

Conditions

GlaucomaDisease

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Justin B Hellman, Bachelors

CONTACT

Eugenio Maul, MD/MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

August 16, 2012

First Posted

August 20, 2012

Study Start

August 1, 2012

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

August 20, 2012

Record last verified: 2012-08

Locations